The Nasdaq Composite has erased early gains as losses for shares of Microsoft Corp. and Nvidia Corp. accelerated, weighing on the broader index. Microsoft shares were down more than 6% earlier, while ...

U.S. stocks opened higher on Thursday, with the Dow shrugging off its premarket losses as investors reacted to the latest batch of corporate earnings and U.S. economic reports. Investors digested the ...

Opthea's lead compound, sozinibercept, targets VEGF-C/D and is in Phase 3 trials for wet AMD. Read more to see why I'm neutral on OPT stock.

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

Discover new preferred stock and exchange-traded debt offerings in January with yields up to 9.125%. Click here to read what investors need to know.

U.S. stock futures moved marginally higher on Thursday following the latest flurry of U.S. economic reports. Investors received the first reading on Q4 GDP. The data showed the U.S. economy expanded ...

Wall Street's major averages move  higher on Thursday, as the Q4 GDP growth came in weaker than expected, while investors digested the tech earnings.

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

It reported sales of $48.4 billion and earnings of $8.02 per share, compared to the consensus estimates of $47.0 billion and ...

Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for Priority Review to be given. Explore more details here.

Nvidia’s AI leadership remains intact, despite DeepSeek concerns. Read why NVDA stock’s steep drop represents a great ...